As the 3D printing industry and all the large players within it continues to expand and evolve, the financial well-being of these companies as they compete to stay on top is a necessity. With sweeping changes being made within some of the larger 3D printing corporations, Belgium’s Materialise (NASDAQ:MTLS) has remained rather quiet when it comes to employee turnover. This all changed though when the company’s current Chief Financial Officer, Frederick Merckx, notified the company’s board back in May that he would be resigning to pursue other career opportunities.
Up until today Materialise, a leader within the 3D printing software and services space, had not announced a replacement for one of their most important positions. Today, however, that announcement came with John Albrecht ready to step in and take over the financial reins of the company.
“We are delighted to welcome Johan to the Materialise team,” stated Executive Chairman of Materialise Peter Leys. “With three decades of experience in finance in an international business environment, Johan is uniquely suited to Materialise. His accomplishments include facilitating BARC’s successful transition in 2007 from a family-owned enterprise to a company with a majority ownership by private equity. Johan’s proven capabilities will help us continue the momentum we have established since becoming a public company last year and leverage the many high-growth opportunities in the 3D printing market worldwide.”
Albrecht seems like he may be a perfect for for the position as he has over 30 years of experience working in roles requiring financial expertise. Way back in 1984, his career began when he took on the role of Financial Analyst at a company called Minit International. From there Albrecht moved on to serve in varying financial capacities for companies within the data research as well as food services industries. Most importantly though, Albrecht has served the last 26 years as the CFO of BARC NV, a central laboratory which supports the biotech and pharmaceutical industries in developing new treatments and drugs. In this role he was responsible for control systems as well as worldwide business and financial reporting.
Albrecht will join Materialise starting tomorrow, July 7, and move into his role as CFO in about 5 weeks on August 12. It will be interesting to see if anything changes from a financial standpoint once he is put into control.
Let’s hear your thoughts on this recent appointment by Materialise, and what it could ultimately mean for the company. Discuss in the Johan Albrecht forum thread on 3DPB.om.
You May Also Like
A Guide to Bioprinting: Understanding a Booming Industry
The success of bioprinting could become the key enabler that personalized medicine, tissue engineering, and regenerative medicine need to become a part of medical arsenals. Breakthroughs in bioprinting will enable...
Cell Culture Bioreactor for Tissue Engineering
Researchers from the US and Portugal are refining tissue engineering applications further, releasing the findings of their study in the recently published ‘A Multimodal Stimulation Cell Culture Bioreactor for Tissue...
3D Printing for Nerve Regeneration: Gelatin Methacrylate-Based Nerve Guidance Conduits
Chinese researchers delve deeply into tissue engineering, releasing the findings of their recent study in ‘3D printing of gelatin methacrylate-based nerve guidance conduits with multiple channels.’ While there have been...
3D Printing: Successful Scaffolds in Bone Regeneration
In ‘Comprehensive Review on Full Bone Regeneration through 3D Printing Approaches,’ the authors review new developments and solutions in tissue engineering for the formation of cells, as well as proposing...
View our broad assortment of in house and third party products.